# Entegris

> Entegris supplies advanced materials, contamination-control products and fluid-handling systems used to manufacture semiconductors. Its portfolio connects process chemistry with filtration and wafer protection, serving chipmakers and their suppliers worldwide.

- **Founded:** 1966
- **Headquarters:** Billerica, United States
- **Founders:** Victor Wallestad (Founder of predecessor Fluoroware)
- **Products:** Torrento liquid filters, GateKeeper gas purification, CMP slurries, pads and post-CMP cleaning, FOUPs and wafer shippers, Advanced deposition materials
- **Notable:** Approximately 4,400 active patents at year-end 2025., US$329 million engineering, research and development investment in 2025., Q2 2026 net sales of US$883.2 million and GAAP operating margin of 18.6%.

## Products & services

- **Torrento liquid filters** — Application-specific filtration for high-purity semiconductor process liquids, including aggressive solvents.
- **GateKeeper gas purification** — Systems for removing trace contaminants from process gases; selected systems target parts-per-trillion purity.
- **CMP slurries, pads and post-CMP cleaning** — Consumables, filtration, monitoring and cleaning products for wafer planarization.
- **FOUPs and wafer shippers** — Protective wafer environments for factory handling and shipment, including Spectra FOUP and SmartStack shippers.
- **Advanced deposition materials** — Precursors used in chemical vapor and atomic layer deposition.
- **Integra valves and fluid management** — High-purity valves, fittings, tubing, containers and chemical delivery components.
- **Analytical and FOUP services** — Contamination analysis, troubleshooting and wafer-carrier support.

## Achievements

- Approximately 4,400 active patents at year-end 2025.
- US$329 million engineering, research and development investment in 2025.
- Q2 2026 net sales of US$883.2 million and GAAP operating margin of 18.6%.
- Global workforce of approximately 7,700.

## Latest updates

- **2026-10** — Q3 2026 results scheduled for October 29; not yet reported as of October 22.
- **2026-10** — Presented CMP research at ICPT 2026 in Seoul, October 19-22.
- **2026-08** — Reported Q2 sales of US$883.2 million, up from US$792.4 million in Q2 2025.
- **2026-08** — Q2 disclosures include restructuring associated with winding down Life Sciences Fluid Management.
- **2026-05** — Announced JSR/Inpria metal oxide resist patent cross-licensing.

## Links

- Website: https://www.entegris.com
- LinkedIn: https://www.linkedin.com/company/entegris
- Twitter/X: https://twitter.com/Entegris
- YouTube: https://www.youtube.com/user/EntegrisInc
- Instagram: https://www.instagram.com/entegrisinc/
- Facebook: https://www.facebook.com/EntegrisInc

---

Profile page: https://yespress.io/entegris
Published by YesPress — https://yespress.io
Last updated: 2026-10-22